CervoMed Inc. (NASDAQ: CRVO)
$19.73
+1.7200 ( +9.55% ) 120.2K
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
Market Data
Open
$19.73
Previous close
$18.01
Volume
120.2K
Market cap
$163.18M
Day range
$17.62 - $20.35
52 week range
$4.28 - $26.38
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Feb 28, 2024 |
8-k | 8K-related | 16 | Feb 28, 2024 |
4 | Insider transactions | 1 | Feb 13, 2024 |
3 | Insider transactions | 2 | Feb 09, 2024 |
8-k | 8K-related | 18 | Feb 07, 2024 |
8-k | 8K-related | 18 | Feb 02, 2024 |
4 | Insider transactions | 1 | Jan 26, 2024 |
4 | Insider transactions | 1 | Jan 26, 2024 |
4 | Insider transactions | 1 | Jan 26, 2024 |
4 | Insider transactions | 1 | Jan 26, 2024 |